Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Yusuf

Showing results (21-30 of 356) with videos related to

Pageof 36
Sort By:
Circulation|May 15, 1996
Cost of prevention. The case of lipid loweringS Yusuf, S Anand
European Heart Journal|January 1, 1996
Using exercise endpoints in heart failure trials: design considerationsS Yusuf, R Tsuyuki
Lancet (London, England)|July 8, 1998
Meta-analysisS Yusuf, J Pogue
European Heart Journal|February 8, 2003
Singapore and coronary heart disease: a population laboratory to explore ethnic variations in the epidemiologic transitionS Ounpuu, S Yusuf
JAMA|May 10, 1995
Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor TrialsR Garg, S Yusuf
Controlled Clinical Trials|June 1, 1989
The likelihood ratio versus the p value in meta-analysis: where is the evidence? Comment on the paper by S. N. GoodmanD Zucker, S Yusuf
Evidence-Based Cardiovascular Medicine|June 1, 1997
Selection of patients for angiography following myocardial infarction was not based on risk but on young age and availability of angiographic facilitiesR Díaz, S Yusuf
JAMA|December 24, 1997
Primary angioplasty compared with thrombolytic therapy for acute myocardial infarctionS Yusuf, J Pogue
Chest|May 1, 1991
Randomized trials to assess the long-term effects of therapies on angiographic end pointsS Yusuf, R Garg
European Heart Journal|May 16, 2002
Urate levels as a predictor of cardiac deaths: causal relation or mere association?S Yusuf, J Bosch
Pageof 36

Showing results (21-30 of 356) with videos related to

Sort By:
Pageof 36
Circulation|May 15, 1996
Cost of prevention. The case of lipid loweringS Yusuf, S Anand
European Heart Journal|January 1, 1996
Using exercise endpoints in heart failure trials: design considerationsS Yusuf, R Tsuyuki
Lancet (London, England)|July 8, 1998
Meta-analysisS Yusuf, J Pogue
European Heart Journal|February 8, 2003
Singapore and coronary heart disease: a population laboratory to explore ethnic variations in the epidemiologic transitionS Ounpuu, S Yusuf
JAMA|May 10, 1995
Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor TrialsR Garg, S Yusuf
Controlled Clinical Trials|June 1, 1989
The likelihood ratio versus the p value in meta-analysis: where is the evidence? Comment on the paper by S. N. GoodmanD Zucker, S Yusuf
Evidence-Based Cardiovascular Medicine|June 1, 1997
Selection of patients for angiography following myocardial infarction was not based on risk but on young age and availability of angiographic facilitiesR Díaz, S Yusuf
JAMA|December 24, 1997
Primary angioplasty compared with thrombolytic therapy for acute myocardial infarctionS Yusuf, J Pogue
Chest|May 1, 1991
Randomized trials to assess the long-term effects of therapies on angiographic end pointsS Yusuf, R Garg
European Heart Journal|May 16, 2002
Urate levels as a predictor of cardiac deaths: causal relation or mere association?S Yusuf, J Bosch
Pageof 36